Cargando…
Functional and Morphological Improvement of Dystrophic Muscle by Interleukin 6 Receptor Blockade
The anti-inflammatory agents glucocorticoids (GC) are the only available treatment for Duchenne muscular dystrophy (DMD). However, long-term GC treatment causes muscle atrophy and wasting. Thus, targeting specific mediator of inflammatory response may be more specific, more efficacious, and with few...
Autores principales: | Pelosi, Laura, Berardinelli, Maria Grazia, De Pasquale, Loredana, Nicoletti, Carmine, D'Amico, Adele, Carvello, Francesco, Moneta, Gian Marco, Catizone, Angela, Bertini, Enrico, De Benedetti, Fabrizio, Musarò, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485902/ https://www.ncbi.nlm.nih.gov/pubmed/26137572 http://dx.doi.org/10.1016/j.ebiom.2015.02.014 |
Ejemplares similares
-
Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice
por: Pelosi, Laura, et al.
Publicado: (2015) -
Increased Circulating Levels of Interleukin-6 Induce Perturbation in Redox-Regulated Signaling Cascades in Muscle of Dystrophic Mice
por: Pelosi, Laura, et al.
Publicado: (2017) -
Increased Circulating Levels of Interleukin-6 Affect the Redox Balance in Skeletal Muscle
por: Forcina, Laura, et al.
Publicado: (2019) -
MicroRNAs modulated by local mIGF-1 expression in mdx dystrophic mice
por: Pelosi, Laura, et al.
Publicado: (2015) -
Chronic exposure to Interleukin-6 amplifies the response to Toll-like receptor ligands: implication on the pathogenesis of macrophage activation syndrome
por: Strippoli, Raffaele, et al.
Publicado: (2011)